Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.7700
+0.0400 (5.48%)
Aug 3, 2026, 5:35 PM CET
Neovacs Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.16 | 0.29 | 0.53 | 0 | 0.02 | |
Revenue Growth | -44.46% | -45.39% | 47868.71% | -95.07% | -24.32% |
Cost of Revenue | 0.26 | 0.32 | 0.5 | 0.58 | 0.48 |
Gross Profit | -0.1 | -0.03 | 0.03 | -0.58 | -0.46 |
Selling, General & Admin | 4.36 | 6.04 | 6.78 | 5.73 | 7.28 |
Depreciation & Amortization Expenses | 0.19 | 0.77 | 0.16 | 0.15 | 0.1 |
Other Operating Expenses | 0.71 | -0.22 | -0 | -0.01 | -0.01 |
Total Operating Expenses | 5.25 | 6.59 | 6.94 | 5.87 | 7.37 |
Operating Income | -5.35 | -6.62 | -6.91 | -6.44 | -7.83 |
Interest Income | 0.83 | 1.16 | 4.52 | 4.24 | 0.05 |
Interest Expense | -0.94 | -20.4 | 0 | 0 | -0 |
Other Non-Operating Income (Expense) | -0.07 | -7.63 | -6.67 | -1.11 | -1.92 |
Total Non-Operating Income (Expense) | -0.18 | -26.87 | -2.15 | 3.13 | -1.87 |
Pretax Income | -5.53 | -33.95 | -9.62 | -4.35 | -12.48 |
Provision for Income Taxes | -0.63 | -1.03 | -0.88 | -0.8 | -0.64 |
Net Income | -4.9 | -32.91 | -8.74 | -3.55 | -11.84 |
Net Income to Common | -4.9 | -32.91 | -8.74 | -3.55 | -11.84 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | - | - | 0 | 0 | 0 |
Shares Outstanding (Diluted) | - | - | 0 | 0 | 0 |
Shares Change | - | - | 420.86% | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5.04 | -3.68 | -2.12 | -4.6 | -10.26 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | - | - | -6.02 | -68.15 | -151.90 |
Gross Margin | -61.86% | -11.20% | 5.50% | -51825.30% | -2051.10% |
Operating Margin | -3306.87% | -2273.11% | -1294.97% | -579583.00% | -34725.60% |
Profit Margin | -3026.84% | -11298.90% | -1639.16% | -319110.00% | -52512.20% |
FCF Margin | -3115.05% | -1263.59% | -396.80% | -413782.00% | -45498.70% |
EBITDA | -4.33 | 0.32 | -1.89 | -5.98 | -7.84 |
EBITDA Margin | -2676.21% | 109.69% | -354.18% | -537591.00% | -34764.00% |
EBIT | -5.35 | -6.62 | -6.91 | -6.44 | -7.83 |
EBIT Margin | -3306.87% | -2273.11% | -1294.97% | -579583.00% | -34725.60% |
Effective Tax Rate | 11.38% | 3.05% | 9.11% | 18.35% | 5.14% |